• COVID-19
  • Allergies and Infant Formula
  • Pharmacology
  • Telemedicine
  • Drug Pipeline News
  • Influenza
  • Allergy, Immunology, and ENT
  • Autism
  • Cardiology
  • Emergency Medicine
  • Endocrinology
  • Adolescent Medicine
  • Gastroenterology
  • Infectious disease
  • Nutrition
  • Neurology
  • Obstetrics-Gynecology & Women's Health
  • Developmental/Behavioral Disorders
  • Practice Improvement
  • Gynecology
  • Respiratory
  • Dermatology
  • Diabetes
  • Mental Health
  • Oncology
  • Psychiatry
  • Animal Allergies
  • Alcohol Abuse
  • Rheumatoid Arthritis
  • Sexual Health
  • Pain

Multisystem inflammatory syndrome in children: A new wrinkle in COVID-19 infection


Contemporary Pediatrics' latest webinar will provide the latest information on multisystem inflammatory syndrome in children associated with COVID-19 infection and provide guidance on how to manage patients who develop the complication, presented by a panel of experts. Register today for the May 20th presentation.

The multisystem inflammatory syndrome in children (MIS-C) associated with coronavirus disease 2019 (COVID-19) has added a new complication to pediatric cases of COVID-19. With over 100 cases in New York state and cases all over the United States and many questions about MIS-C remain.

This past Wednesday, Contemporary Pediatrics hosted a webinar that untangled MIS-C and provided the latest information and guidance about the condition. It was moderated by Tina Q. Tan, MD, FAACP, FIDSA, FPIDS, and featuring experts Stanford T. Shulman, MD, and Leonard R. Krilov, MD.

For an on-demand version of the webinar, click here.

Related Videos
Importance of maternal influenza vaccination recommendations
Reducing HIV reservoirs in neonates with very early antiretroviral therapy | Deborah Persaud, MD
Samantha Olson, MPH
Deborah Persaud, MD
Ari Brown, MD, FAAP | Pediatrician and CEO of 411 Pediatrics; author, baby411 book series; chief medical advisor, Kabrita USA.
Steven Selbst, MD
© 2024 MJH Life Sciences

All rights reserved.